MoneyAM MoneyAM
 Home   Log In   Register   Our Services   My Account   Contact   Help 
 Stockwatch   Level 2   Portfolio   Charts   Research   Share Price   Awards   Indices   Market Scan   Company Zone   Traders' Room 
 Funds   Trades   Terminal   Alerts   Heatmaps   News   Stock Screener   Forward Diary   Forex Prices   Director Deals   Investors' Room 
 CFDs   Shares   SIPPs   ISAs   Forex   ETFs   Videos   Comparison Tables   Spread Betting   Broker Notes   Shares Magazine 
You are NOT currently logged in

 
Filter Criteria  
Epic: Keywords: 
From: Time:  (hh:mm) RNS:  MonAM: 
To: Time:  (hh:mm)
Please Note - Streaming News is only available to subscribers to the Active Level and above
 


CVS ‘well placed’ to deliver annual growth on strong sales momentum

ALN

CVS Group PLC on Wednesday said that while it remained mindful of wider macroeconomic uncertainties, it expected to deliver further sales growth in line with expectations over the financial year.

CVS is a Norfolk, England-based veterinary services provider, with practices in the Netherlands and Ireland.

For the four months to October 31, the company reported total sales growth of 7.4% versus the same period last year. Similarly, like-for-like sales increased by 7.4%, within previously stated guidance of organic revenue growth between 4% and 8%.

CVS attributed this to a ‘positive performance’ across all business areas, with continued resilient customer demand for its range of integrated veterinary services.

The Healthy Pet Club preventative care scheme saw a further increase in membership with 479,000 members at October 31, from 458,000 members the previous year.

CVS said that it continues to benefit from its integrated veterinary platform, with adjusted earnings before interest, taxes, depreciation and amortisation in line with expectations at 19%.

Over the period, the group also completed a further two acquisitions, bringing its total to four, comprising seven practice sites in the financial year to date for an initial consideration of £22.1 million.

CVS also said it had begun a formal search process for an additional non-executive director in the previous financial year.

Looking ahead, the company intends to invest in its practices and clinical equipment to drive organic growth, whilst continuing to explore acquisition opportunities.

Though mindful of wider macroeconomic uncertainties, CVS expects trading in line with full year market expectations.

The company will pay a dividend of 7.0 pence per share.

CVS shares were trading 3.2% higher at 1,988.00p each in London on Wednesday morning.

Copyright 2022 Alliance News Limited. All Rights Reserved.